Company record
Zydus Pharmaceuticals (USA) Inc
0 FDA warning letters since 2023 and 8 recalls in the last 12 months.
Get an email the day FDA posts anything new about Zydus Pharmaceuticals (USA) Inc.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 21 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, … Failed Impurities/Degradation Specifications. |
| Aug 12 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-… CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. |
| May 27 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3). CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit |
| May 27 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (… CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit |
| Mar 18 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7 Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient. |
| Jan 28 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07 Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules |
| Jan 7 | Class III | Zydus Pharmaceuticals (USA) Inc Drug |
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10 Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. |
| Nov 26, 2025 | Class II | Zydus Pharmaceuticals (USA) Inc Drug |
Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06 Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules. |